LAGIPRA peptide (TFA)

Produktübersicht

• Artikelname: LAGIPRA peptide (TFA)
• Artikelnummer: MCE-HY-P11285A
• Hersteller Artikelnummer: HY-P11285A
• Alternativnummer: MCE-HY-P11285A-25MG,MCE-HY-P11285A-10MG,MCE-HY-P11285A-5MG,MCE-HY-P11285A-1MG,MCE-HY-P11285A-50MG
• Hersteller: MedchemExpress
• Kategorie: Proteine/Peptide
• Alternative Synonym: Long acting GIPRA-1 (TFA)

Produktbeschreibung

LAGIPRA peptide TFA is a long-acting GIP1R agonist. LAGIPRA peptide TFA enhances insulin sensitivity by augmenting glucose disposal and reduces branched-chain amino acids (BCAAs) and ketoacids. LAGIPRA peptide TFA has the potential for the research of type 2 diabetes[1].

Produkteigenschaften

• Molekulargewicht: 5756.50 (free base)
• Reinheit: 98.20
• Formel: C264H406N64O78S.xC2HF3O2
• Target-Kategorie: Insulin Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Peptides